We are live on ! Find out more
BBA

Baker Bros. Advisors Portfolio holdings

AUM $17.4B
1-Year Est. Return 131.5%
This Fund
S&P 500
This Quarter Est. Return
+35.46%
1 Year Est. Return
+131.5%
3 Year Est. Return
+336.81%
5 Year Est. Return
+553.16%
10 Year Est. Return
+4,134.93%
AUM
$17.1B
AUM Growth
+$3.24B
Cap. Flow
+$452M
Cap. Flow %
2.65%
Top 10 Hldgs %
74.38%
Holding
100
New
9
Increased
23
Reduced
7
Closed
14

Top Buys

1
KYMR icon
Kymera Therapeutics
KYMR
+$135M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$92.2M
3
PRAX icon
Praxis Precision Medicines
PRAX
+$81.4M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$60.9M
5
ALKS icon
Alkermes
ALKS
+$57.5M

Top Sells

1
MRUS
Merus
MRUS
+$54.1M
2
NTLA icon
Intellia Therapeutics
NTLA
+$47.4M
3
STOK icon
Stoke Therapeutics
STOK
+$39M
4
RNAM
Avidity Biosciences
RNAM
+$27.2M
5
PCVX icon
Vaxcyte
PCVX
+$23.1M

Sector Composition

1 Healthcare 99.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FDMT icon
76
4D Molecular Therapeutics
FDMT
$612M
$3.57M 0.02%
+475,737
New +$4.83M
VIR icon
77
Vir Biotechnology
VIR
$1.6B
$3.27M 0.02%
542,539
– –
TCRX icon
78
TScan Therapeutics
TCRX
$60.8M
$2.78M 0.02%
2,784,792
– –
SANA icon
79
Sana Biotechnology
SANA
$994M
$1.26M 0.01%
310,483
-1,720,466
-85% -$7.7M
SKYE icon
80
Skye Bioscience
SKYE
$21.8M
$1.09M 0.01%
1,450,638
– –
KALA icon
81
KALA BIO
KALA
$17.9M
$1M 0.01%
36,081
+16,379
+83% +$733K
ALGS icon
82
Aligos Therapeutics
ALGS
$37.8M
$774K ﹤0.01%
83,055
– –
TYRA icon
83
Tyra Biosciences
TYRA
$1.96B
$279K ﹤0.01%
10,607
– –
ACRV icon
84
Acrivon Therapeutics
ACRV
$91.2M
$55K ﹤0.01%
22,809
– –
SRZNW icon
85
Surrozen Inc Warrant
SRZNW
$41.1K
$16.7K ﹤0.01%
833,333
– –
ACLX
86
DELISTED
Arcellx
ACLX
– –
-166,825
Closed -$13.7M
AGIO icon
87
Agios Pharmaceuticals
AGIO
$2.37B
– –
-189,866
Closed -$7.62M
AKRO
88
DELISTED
Akero Therapeutics
AKRO
– –
-324,630
Closed -$15.4M
CDTX
89
DELISTED
Cidara Therapeutics
CDTX
– –
-227,272
Closed -$21.8M
GBIO
90
DELISTED
Generation Bio
GBIO
– –
-194,493
Closed -$1.19M
HRTX icon
91
Heron Therapeutics
HRTX
$81.4M
– –
-4,251,951
Closed -$5.36M
MRUS
92
DELISTED
Merus
MRUS
– –
-574,377
Closed -$54.1M
NTLA icon
93
Intellia Therapeutics
NTLA
$1.86B
– –
-2,746,674
Closed -$47.4M
PCVX icon
94
Vaxcyte
PCVX
$8.12B
– –
-640,885
Closed -$23.1M
RNAM
95
DELISTED
Avidity Biosciences
RNAM
– –
-625,000
Closed -$27.2M
VKTX icon
96
Viking Therapeutics
VKTX
$4.41B
– –
-366,083
Closed -$9.62M
VYNE icon
97
VYNE Therapeutics
VYNE
$23.7M
– –
-851,353
Closed -$285K
MBX
98
MBX Biosciences
MBX
$2.69B
– –
-277,777
Closed -$4.86M
OPT
99
DELISTED
Opthea Limited American Depositary Shares
OPT
– –
-2,087,320
Closed –
1 2 3
4

Similar funds

MCM
MAI Capital Management Independence, Ohio $17.6B AUM 18.87% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $17.8B AUM 21.2% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $16.9B AUM 31.69% 1-Year Est. Return